These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 16214811)
81. Helicase-Driven Activation of NFκB-COX2 Pathway Mediates the Immunosuppressive Component of dsRNA-Driven Inflammation in the Human Tumor Microenvironment. Theodoraki MN; Yerneni S; Sarkar SN; Orr B; Muthuswamy R; Voyten J; Modugno F; Jiang W; Grimm M; Basse PH; Bartlett DL; Edwards RP; Kalinski P Cancer Res; 2018 Aug; 78(15):4292-4302. PubMed ID: 29853604 [TBL] [Abstract][Full Text] [Related]
82. Nucleotide-binding oligomerization domain 1 and Minaga K; Watanabe T; Kamata K; Asano N; Kudo M World J Gastroenterol; 2018 Apr; 24(16):1725-1733. PubMed ID: 29713127 [TBL] [Abstract][Full Text] [Related]
83. Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of Schleicher U; Liese J; Justies N; Mischke T; Haeberlein S; Sebald H; Kalinke U; Weiss S; Bogdan C Front Immunol; 2018; 9():79. PubMed ID: 29459858 [TBL] [Abstract][Full Text] [Related]
84. Sirtuin 1-Chromatin-Binding Dynamics Points to a Common Mechanism Regulating Inflammatory Targets in SIV Infection and in the Aging Brain. Bortell N; Basova L; Najera JA; Morsey B; Fox HS; Marcondes MCG J Neuroimmune Pharmacol; 2018 Jun; 13(2):163-178. PubMed ID: 29280055 [TBL] [Abstract][Full Text] [Related]
85. The expression profile of IFITM family gene in rats. Lu Y; Zuo Q; Zhang Y; Wang Y; Li T; Han J Intractable Rare Dis Res; 2017 Nov; 6(4):274-280. PubMed ID: 29259856 [TBL] [Abstract][Full Text] [Related]
87. Toll-Like Receptor 4, but Not Neutrophil Extracellular Traps, Promote IFN Type I Expression to Enhance Th2 Responses to Pellefigues C; Tang SC; Schmidt A; White RF; Lamiable O; Connor LM; Ruedl C; Dobrucki J; Le Gros G; Ronchese F Front Immunol; 2017; 8():1575. PubMed ID: 29201030 [TBL] [Abstract][Full Text] [Related]
88. Nucleotide-binding oligomerization domain 1 and gastrointestinal disorders. Watanabe T; Asano N; Kudo M; Strober W Proc Jpn Acad Ser B Phys Biol Sci; 2017; 93(8):578-599. PubMed ID: 29021509 [TBL] [Abstract][Full Text] [Related]
89. Ubiquitination of STING at lysine 224 controls IRF3 activation. Ni G; Konno H; Barber GN Sci Immunol; 2017 May; 2(11):. PubMed ID: 28763789 [TBL] [Abstract][Full Text] [Related]
90. PRDM16 represses the type I interferon response in adipocytes to promote mitochondrial and thermogenic programing. Kissig M; Ishibashi J; Harms MJ; Lim HW; Stine RR; Won KJ; Seale P EMBO J; 2017 Jun; 36(11):1528-1542. PubMed ID: 28408438 [TBL] [Abstract][Full Text] [Related]
91. The viral innate immune antagonism and an alternative vaccine design for PRRS virus. Ke H; Yoo D Vet Microbiol; 2017 Sep; 209():75-89. PubMed ID: 28341332 [TBL] [Abstract][Full Text] [Related]
92. Absent in Melanoma 2 proteins in SLE. Choubey D; Panchanathan R Clin Immunol; 2017 Mar; 176():42-48. PubMed ID: 28062222 [TBL] [Abstract][Full Text] [Related]
93. A novel anti-viral role for STAT3 in IFN-α signalling responses. Mahony R; Gargan S; Roberts KL; Bourke N; Keating SE; Bowie AG; O'Farrelly C; Stevenson NJ Cell Mol Life Sci; 2017 May; 74(9):1755-1764. PubMed ID: 27988795 [TBL] [Abstract][Full Text] [Related]
94. Differential Production of Type I IFN Determines the Reciprocal Levels of IL-10 and Proinflammatory Cytokines Produced by C57BL/6 and BALB/c Macrophages. Howes A; Taubert C; Blankley S; Spink N; Wu X; Graham CM; Zhao J; Saraiva M; Ricciardi-Castagnoli P; Bancroft GJ; O'Garra A J Immunol; 2016 Oct; 197(7):2838-53. PubMed ID: 27549173 [TBL] [Abstract][Full Text] [Related]
95. Interferon regulatory factor 3 is a key regulation factor for inducing the expression of SAMHD1 in antiviral innate immunity. Yang S; Zhan Y; Zhou Y; Jiang Y; Zheng X; Yu L; Tong W; Gao F; Li L; Huang Q; Ma Z; Tong G Sci Rep; 2016 Jul; 6():29665. PubMed ID: 27411355 [TBL] [Abstract][Full Text] [Related]
97. Ablation of Type-1 IFN Signaling in Hematopoietic Cells Confers Protection Following Traumatic Brain Injury. Karve IP; Zhang M; Habgood M; Frugier T; Brody KM; Sashindranath M; Ek CJ; Chappaz S; Kile BT; Wright D; Wang H; Johnston L; Daglas M; Ates RC; Medcalf RL; Taylor JM; Crack PJ eNeuro; 2016; 3(1):. PubMed ID: 27022620 [TBL] [Abstract][Full Text] [Related]
98. Sequential Activation of Two Pathogen-Sensing Pathways Required for Type I Interferon Expression and Resistance to an Acute DNA Virus Infection. Xu RH; Wong EB; Rubio D; Roscoe F; Ma X; Nair S; Remakus S; Schwendener R; John S; Shlomchik M; Sigal LJ Immunity; 2015 Dec; 43(6):1148-59. PubMed ID: 26682986 [TBL] [Abstract][Full Text] [Related]
99. Multifunctional roles of leader protein of foot-and-mouth disease viruses in suppressing host antiviral responses. Liu Y; Zhu Z; Zhang M; Zheng H Vet Res; 2015 Oct; 46():127. PubMed ID: 26511922 [TBL] [Abstract][Full Text] [Related]
100. IFNA2: The prototypic human alpha interferon. Paul F; Pellegrini S; Uzé G Gene; 2015 Aug; 567(2):132-7. PubMed ID: 25982860 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]